1.Mechanism of Postprandial Drowsiness and the Clinical Application under the Model of Wei Qi Circulating from Yin to Yang
Pengfei KANG ; Boju SUN ; Conghui WANG ; Xiangmei CHEN
Journal of Traditional Chinese Medicine 2025;66(8):769-774
Postprandial drowsiness is a clinical condition characterized by pronounced drowsiness after meals, while The Inner Canon of Yellow Emperor (《黄帝内经》) associates this condition with wei qi (defensive qi). By analyzing the original texts of The Inner Canon of Yellow Emperor and perspectives from many medical professionals, it is found that the transition between wakefulness and sleep depends on the mutual induction of yin and yang, and that the two pathways of wei qi circulation intersect at the spleen and stomach. Based on this, the core pathogenesis of postprandial drowsiness is proposed to be either upper jiao obstruction or spleen-stomach dysfunction, leading to the stagnation of wei qi internally, then the mutual induction of yin and yang causes inward invasion of wei qi in the body, resulting in drowsiness; at this stage, the stagnated and inward invasive wei qi converges at the spleen and stomach, then merges into the circulation of zang-fu organs, rerouting through the Foot Taiyang Meridian, forming a circulation pattern described as "circulating from yin to yang". Treatment should focus on the root and branch simultaneously, with the primary goal of regulating the circulation of wei qi; facilitating its transition from yin to yang to restore the sleep-wake cycle. By proposing the model of wei qi circulating from yin to yang, this study offers novel insights on the understanding of postprandial drowsiness.
2.Integrated evidence chain-based effectiveness evaluation of traditional Chinese medicines (Eff-iEC): A demonstration study.
Ye LUO ; Xu ZHAO ; Ruilin WANG ; Xiaoyan ZHAN ; Tianyi ZHANG ; Tingting HE ; Jing JING ; Jianyu LI ; Fengyi LI ; Ping ZHANG ; Junling CAO ; Jinfa TANG ; Zhijie MA ; Tingming SHEN ; Shuanglin QIN ; Ming YANG ; Jun ZHAO ; Zhaofang BAI ; Jiabo WANG ; Aiguo DAI ; Xiangmei CHEN ; Xiaohe XIAO
Acta Pharmaceutica Sinica B 2025;15(2):909-918
Addressing the enduring challenge of evaluating traditional Chinese medicines (TCMs), the integrated evidence chain-based effectiveness evaluation of TCMs (Eff-iEC) has emerged. This paper explored its capacity through a demonstration study that evaluated the effectiveness evidence of six commonly used anti-hepatic fibrosis Chinese patent medicines (CPMs), including Biejiajian Pill (BP), Dahuang Zhechong Pill (DZP), Biejia Ruangan Compound (BRC), Fuzheng Huayu Capsule (FHC), Anluo Huaxian Pill (AHP), and Heluo Shugan Capsule (HSC), using both Eff-iEC and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system. The recognition of these CPMs within the TCM academic community was also assessed through their inclusion in relevant medical documents. Results showed that the evidence of BRC and FHC received higher assessments in both Eff-iEC and GRADE system, while the assessments for others varied. Analysis of community recognition revealed that Eff-iEC more accurately reflects the clinical value of these CPMs, exhibiting superior evaluative capabilities. By breaking through the conventional pattern of TCMs effectiveness evaluation, Eff-iEC offers a novel epistemology that better aligns with the clinical realities and reasoning of TCMs, providing a coherent methodology for clinical decision-making, new drug evaluations, and health policy formulation.
3.Correlation of enzyme activities and genotype with clinical manifestations in Chinese patients of different sexes with classical and late-onset Fabry disease.
Wenkai GUO ; Yuansheng XIE ; Pengcheng JI ; Qinggang LI ; Peng WANG ; Guangyan CAI ; Xiangmei CHEN
Frontiers of Medicine 2025;19(3):523-537
Fabry disease, a rare genetic disorder affecting multiple organs, has understudied correlations among enzyme activity, genotype, and clinical manifestations in patients of different sexes with classical and late-onset phenotypes. In this study, clinical data, α-Gal A activity, and GLA gene test results of 311 patients, who were categorized by classical and late-onset phenotypes, ⩽5% and > 5% of the normal mean value of enzyme activity, and truncated and nontruncated mutation groups, were collected. The common clinical manifestations of Fabry disease included acroparesthesia, hypohidrosis/anhidrosis, neuropsychiatric system, and renal and cardiovascular involvement. Multiorgan involvement was higher in males and classical phenotype patients. In both sexes, classical patients commonly presented with acroparesthesia and multiorgan involvement, whereas late-onset patients showed renal, neuropsychiatric, and cardiovascular involvement. Male and classical patients had lower enzyme activity than female and late-onset patients, respectively. Classical males with enzyme activity of ⩽5% of the normal mean level showed higher multiorgan involvement frequency than those with enzyme activity of > 5%, whereas no significant difference was observed among females. Ninety-five gene mutation sites were detected, with significant phenotype heterogeneity in patients with the same mutation. No significant difference in enzyme activity or clinical manifestations was observed between truncated and nontruncated mutations. Overall, male patients with Fabry disease, regardless of classical or late-onset phenotype, have a higher frequency of multiple-organ involvement and lower α-Gal A activity than female patients. α-Gal A activity was closely correlated with clinical symptoms in males but weakly correlated with clinical manifestations in females. The clinical manifestations of patients with the same mutation are heterogeneous, and the correlation between gene mutation and enzyme activity or clinical manifestation is weak.
Adolescent
;
Adult
;
Aged
;
Female
;
Humans
;
Male
;
Middle Aged
;
Young Adult
;
Age of Onset
;
alpha-Galactosidase/metabolism*
;
China
;
Fabry Disease/enzymology*
;
Genotype
;
Mutation
;
Phenotype
;
Sex Factors
;
East Asian People/genetics*
4.Application of the novel bag respirator assisted ventilation device in postoperative transport under general anesthesia with laryngeal mask
Qing ZENG ; Li TAN ; Xiangmei YANG ; Yan LUO ; Bin WANG ; Jing YAN
Journal of Chongqing Medical University 2025;50(5):682-687
Objective:To explore the application value of a novel bag respirator assisted ventilation device in postoperative transport under general anesthesia with laryngeal mask.Methods:A total of 133 patients in postoperative transport who underwent elective bron-choscopy or treatment under general anesthesia with laryngeal mask in the First Affiliated Hospital of Chongqing Medical University,from June to August 2023 were selected.The patients were randomly divided into control group(n=65)and experimental group(n=68),and received manual bag respirator assisted ventilation and the novel bag respirator assisted ventilation device during their postop-erative transport,respectively.The pulse oxygen saturation(SpO2),heart rate(HR),and ventilation frequency during transport,trans-port duration,and transport-related adverse events were compared between the two groups.Results:The difference in SpO2 was signifi-cant when comparing the two groups(Fbetween groups=18.588,P<0.001),and the SpO2 of patients in the experimental group was signifi-cantly higher than that of patients in the control group during and after transport(P<0.001).The difference in HR was not significant when comparing the two groups(Fbetween groups=0.089,P=0.766),but it was significant between the control and experimental groups before and after transport(Ftime point=12.430,P<0.001);the HR in the con-trol and experimental groups before and during transport was signifi-cantly lower than that after transport(all P<0.001).The ventilation frequency of the experimental group was significantly lower than that of the control group(P<0.001).The transport duration in the ex-perimental group was longer than that in the control group,but the difference was not significant(P=0.987).Both groups successfully completed the trial without transport-related adverse events and achieved safe transport.Conclusion:Compared with the manual bag respirator assisted ventilation technology,the novel bag respirator assisted ventilation device for respiratory support during postopera-tive transport in patients under general anesthesia with laryngeal mask is more able to reduce the impact on the patient's hemodynam-ics and conducive to the maintenance of the patient's stable vital signs,showing a good clinical application value.It is expected to be a safe and effective ventilation method during intrahospital transport in some patients under general anesthesia.
5.Predictive value of ultrasound scoring system combined with serum creatine kinase,VEGF and AFP for the degree of placental implantation in parturients
Journal of Navy Medicine 2025;46(10):1026-1031
Objective To evaluate the value of ultrasound scoring system combined with serum levels of creatine kinase(CK),vascular endothelial growth factor(VEGF),and alpha-fetoprotein(AFP)in predicting the degree of placental implantation in parturients.Methods A total of 137 pregnant women with placental implantation disorders who were admitted to Xi'an Daxing Hospital from January 2020 to January 2024 were enrolled in this retrospective study.Pathological examination revealed 101 cases of adhesion type and 36 cases of implantation and penetration types.Clinical data were collected.All the patients underwent ultrasonic examination and were scored using an ultrasound scoring system.Multivariate Logistic regression analysis was employed to assess the factors influencing the degree of placental implantation.The predictive value of the ultrasound scoring system and serum markers for the degree of placental implantation was analyzed using receiver operating characteristic(ROC)curves.Results The transfusion rate of allogeneic red blood cell and ultrasound score in patients with implantation and penetration types were significantly higher than those in patients with adhesion type(55.56%vs.14.85%,5.97±1.23 vs.2.52±1.20,P<0.05).Serum levels of CK,VEGF and AFP in patients with implantation and penetration types were also significantly higher than those in patients with adhesion type([151.94±51.02]U/L vs.[121.37±43.01]U/L,[251.64±52.09]pg/mL vs.[151.67±31.08]pg/ml,[234.95±43.01]ng/mL vs.[205.64±35.12]ng/ml,P<0.05).Ultrasound findings such as the disappearance of the clear zone,abnormal placental lacunae,disruption of the bladder boundary,thinning of the myometrium,placental protrusion,extrusion of local tissue,high vascularization between the uterus and bladder,high vascularization behind the placenta,vascular bridges,and direct blood vessels in the placental bed were significantly more frequent in patients with implantation and penetration types compared to the adhesion type(P<0.05).Multivariate Logistic regression analysis indicated that allogeneic red blood cell transfusion rate,ultrasound score,and serum levels of CK,VEGF and AFP were independent risk factors for a higher degree of placental implantation,with odds ratios of 5.363,1.810,1.015,1.019,and 1.020(95%CI:1.410-20.404,1.197-2.736,1.000-1.030,1.004-1.035,1.002-1.038,P<0.05).The combined predictive value of ultrasound scoring and serum levels of CK,VEGF and AFP showed the highest sensitivity(94.40%)and specificity(97.00%)for the degree of placental implantation in patients with implantation and penetration types,with a Youden index of 0.914 and an AUC of 0.937(95%CI:0.874-0.999).Conclusion The ultrasound scoring system combined with serum CK,VEGF and AFP can effectively predict the severity of placental implantation.This combined approach offers high sensitivity and specificity for identifying high-risk cases of implantation and penetration types of placental implantation,thereby aiding clinicians in optimizing management and intervention strategies for pregnant women.
6.Future-Oriented High-Quality Development of Integrated Traditional Chinese and Western Medicine
Xiangmei CHEN ; Conghui WANG ; Qinxiu ZHANG ; Yan LI ; Yong TANG
Journal of Sichuan University (Medical Sciences) 2025;56(1):1-4
Integrated traditional Chinese and Western medicine refers to a clinical diagnosis and treatment model that incorporates the essence of traditional Chinese medicine in regard to treatment decisions based on syndrome differentiation and a reliance on modern western medicine as the basis of diagnosis and treatment.It is an organic combination of the two,with each bringing its own strengths into full play and complementing those of the other.After the founding of the People's Republic of China,the development of the integrated traditional Chinese and Western medicine has been increasingly valued.The unique advantages of the integration of traditional Chinese and Western medicine have been continuously utilized,resulting in fruitful achievements in theoretical inheritance and innovation and in the prevention and treatment of major diseases.Furthermore,integrated traditional Chinese and Western medicine has become a unique system of medicine of China.This article provides a review and elaboration of the entire process of the integration of traditional Chinese and Western medicine,including its significance,status of development,and achievements.It is suggested that,in the field of integrated traditional Chinese and Western medicine,efforts should made to delve into classic theories,identify the right entry points for integration,reconstruct and improve the theoretical system of integrated traditional Chinese and Western medicine by combining the cutting-edge achievements of modern medicine,and focus on enhancing clinical efficacy.
7.Expression of AU-rich element RNA-binding factor 1 in hepatocellular carcinoma and its value in prognostic evaluation
Yuan DUAN ; Ting ZHANG ; Jing ZHANG ; Guiwen GUAN ; Jingzhou WANG ; Xiangmei CHEN
Journal of Clinical Hepatology 2024;40(9):1833-1839
Objective To investigate the effect of AU-rich element RNA-binding factor 1(AUF1)on the proliferation,apoptosis,and migration abilities of hepatocellular carcinoma(HCC)cells and possible mechanisms,and to clarify the role and molecular mechanism of AUF1 in the progression of HCC.Methods The UALCAN and TCGA-HCC databases were used to analyze the expression of AUF1 in pan-cancer and investigate the association of the expression level of AUF1 with the clinicopathological features and prognosis of HCC patients.CCK-8 assay,cell apoptosis assay,and Transwell chamber assay were used to investigate the function of AUF1 at the cellular level,and RNA-seq assay was used to investigate transcriptome changes in HCC cells after AUF1 knockdown.The t-test was used for comparison of continuous data between two groups;the Kaplan-Meier method was used to plot survival curves,and the log-rank test was used for comparison of survival rates.Results There were abnormal mRNA and protein expression levels of AUF1 in various tumor tissues compared with normal tissue(P<0.05).The mRNA expression level of AUF1 was positively correlated with the degree of HCC malignancy and the poor prognosis of early-stage HCC(P<0.05).Compared with the control group,the overexpression of exogenous AUF1 in HCC cells promoted the proliferation of HCC cells and inhibited the apoptosis and migration of HCC cells,while AUF1 knockdown inhibited HCC cell proliferation and promoted the apoptosis and migration of HCC cells.The RNA-seq analysis showed that AUF1 knockdown mainly affected the Wnt/β-catenin pathway and downregulated the protein expression level of β-catenin.Conclusion The abnormal expression of AUF1 is associated with the prognosis of early-stage HCC,and AUF1 may exert an oncogenic effect by activating the Wnt signaling pathway.
8.Successful trans-blood liver transplantation after artificial liver support therapy in a patient with hepatic coma: A case report
Shuang SUN ; Jinquan LIU ; Shuai FENG ; Shuxian WANG ; Xiangmei XU ; Deshu DAI ; Jianhong WANG ; Jinzhen CAI ; Chuanshen XU
Journal of Clinical Hepatology 2024;40(4):791-793
This article reports a patient with hepatic coma who underwent artificial liver support therapy and liver transplantation successfully, and the patient recovered well in the later stage after active treatment. This article also discusses the timing of liver transplantation.
9.The role of serum cholinesterase in the prognosis assessment of patients with acute decompensated heart failure
Xiangmei ZHAO ; Yaxin XU ; Zehua WANG ; Lijuan JING ; Haijia YU ; Xianzhi YANG ; Lei YANG ; Lijie QIN
Chinese Journal of Emergency Medicine 2024;33(2):234-241
Objective:To explore the role of serum cholinesterase (CHE) levels in the prognosis of patients with acute decompensated heart failure (ADHF).Methods:Total of 244 consecutive patients with ADHF who were admitted to the emergency department and were successfully discharged were prospectively enrolled from January 2018 to June 2020. Patients were divided into groups according to the first and third quartile of CHE level and the clinical data, laboratory tests and other nutritional indices were recorded after discharge, and then were followed up. The primary end points were the composites of cardiovascular death and hospitalization for worsening HF (composite end points). The secondary end points were all-cause mortality and cardiovascular death. Cox proportional risk analysis, time-dependent Cox regression model or stratified cox regression were used to identify the risk of primary and secondary endpoints. Clinical, biomarker and the compound models of clinical and biomarker were constructed. Kaplan-Meier method was used to plot the survival curves of different groups and compare their differences. Receiver Operating characteristics (ROC) curves were used to compare the area under the curve for CHE levels and other nutritional or prognostic indicators to identify composite end-point events.Results:During a follow-up period of 350(100,683) days, 158 patients reached the composite end points. In the multivariable Cox analysis, cholinesterase level was significantly associated with the composite end points after adjustment for major confounders. Cox proportional risk analysis or time-dependent Cox regression model showed that CHE level was significantly associated with the composite end points, all-cause mortality and cardiovascular mortality in both clinical, biomarker and composite models (all P< 0.05). A Kaplan–Meier analysis revealed that patients with low cholinesterase levels had significantly greater risk of reaching the composite end points than those with middle or high cholinesterase levels (78.1% vs 66.7% vs. 46.7%, P<0.001); Cholinesterase level showed the largest area under the receiver operating characteristic curve (AUROC) of 0.736 (95% CI, 0.664-0.888) for prediction of the composite end points among other nutritional indices. The AUROC of the Global Meta-Analysis Group Chronic Heart Failure (MAGGIC) Risk Score for prediction of the composite end points was increased from 0.704 to 0.762 ( P=0.038), when cholinesterase level was added. Conclusions:Cholinesterase may serve as a simple and effective prognostic marker for predicting adverse outcomes in ADHF patients.
10.Clinicopathological features of Sjogren′s syndrome complicated with liver injury
Xiaoyi HAN ; Liang ZHANG ; Kun YANG ; Jiamin CHEN ; Xingang ZHOU ; Xiangmei CHEN ; Zhiyuan MA ; Liming QI ; Peng WANG ; Lei SUN
Chinese Journal of Pathology 2024;53(4):377-383
Objective:To study the clinicopathological features of Sjogren′s syndrome (SS) with liver injury and to improve the understanding of this disease.Methods:Forty-nine patients with SS complicated with liver injury were collected from Beijing Ditan Hospital, Capital Medical University from October 2008 to January 2022. All patients underwent ultrasound-guided liver biopsy, and all specimens were stained with HE. The histopathologic characteristics were observed and the pathologic indexes were graded. Immunohistochemical stains for CK7, CK19, CD38, MUM1 and CD10 were performed by EnVision method; and special histochemical stains for reticulin, Masson′s trichrome, Rhodanine, Prussian blue, periodic acid Schiff (PAS) and D-PAS stains were conducted .Results:The age of patients ranged from 31 to 66 years, including 3 males and 46 females. SS combined with drug-induced liver injury was the most common (22 cases, 44.9%), followed by autoimmune liver disease (13 cases, 26.5%, including primary biliary cholangitis in eight cases, autoimmune hepatitis in 3 cases, and PBC-AIH overlap syndrome in 2 cases), non-alcoholic fatty liver disease (NAFLD, 9 cases, 18.4%) and other lesions (5 cases, 10.2%; including 3 cases of nonspecific liver inflammation, 1 case of liver amyloidosis, and 1 case of porto-sinusoidal vascular disease). Among them, 28 cases (57.1%) were associated with obvious interlobular bile duct injury, mainly in SS combined with PBC group and drug-induced liver injury group. Twenty-three cases (46.9%) were associated with hepatocyte steatosis of varying degrees. In SS with autoimmune liver disease group, ISHAK score, degree of fibrosis bile duct injury, bile duct remodeling, lymphocyte infiltration of portal area, and plasma cell infiltration, MUM1 and CD38 expression; serum ALP and GGT, IgM; elevated globulin; positive AMA, proportion of AMA-M2 positive and IgM positive were all significantly higher than those in other groups(all P<0.05). Serum ALT, direct bilirubin and SSA positive ratio in SS combined with drug liver group were significantly higher than those in other groups(all P<0.05). The serum total cholesterol level in SS combined with PBC group ( P=0.006) and NALFD group ( P=0.011) were significantly higher than those in other groups ( P<0.05). Conclusions:The pathologic manifestations of SS patients with liver injury are varied. The inflammatory lesions of SS patients with autoimmune liver disease are the most serious, and the inflammatory lesions of SS patients with non-alcoholic fatty liver disease and non-specific inflammation are mild. Comprehensive analysis of liver histopathologic changes and laboratory findings is helpful for the diagnosis of SS complicated with different types of liver injury.

Result Analysis
Print
Save
E-mail